Riluzole hydrochloride NEW
| Price | $31 | $44 |
| Package | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: Riluzole hydrochloride | CAS No.: 850608-87-6 |
| Purity: 99.87% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | Riluzole hydrochloride |
| Description | Riluzole hydrochloride (PK 26124 hydrochloride) is an anticonvulsant compound belonging to the family of sodium channel blockers that inhibits GABA uptake.Riluzole hydrochloride is a sodium-glutamate antagonist with anticancer and neuroprotective activity and can be used to study amyotrophic lateral sclerosis and neurological disorders. |
| In vitro | Riluzole hydrochloride (20-100 μM) significantly prolonged the decay of IPSCs, resulting in almost no change in the total charge transfer[1]. |
| In vivo | Riluzole hydrochloride (8 mg/kg;i.p.) can inhibit auditory and aversive emotional responses in adult rats with arthritis, but does not affect spinal withdrawal thresholds[2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 80 mg/mL (295.57 mM), Sonication is recommended. H2O : 2 mg/mL (7.39 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (12.19 mM), Sonication is recommended. |
| Keywords | GABAReceptor | GABA uptake | GABA Receptor |
| Inhibitors Related | Phenytoin sodium | Procaine | p-Hydroxybenzaldehyde | Urethane | Lidocaine | Penicillin G sodium salt | Valproic Acid | L-Aspartic aicd sodium | Methyl eugenol | (-)-α-Pinene | Dihydromyricetin | Methionine |
| Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY